Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 May 2011 10:00

RNS Number : 9111G
British Smaller Companies VCT2 Plc
19 May 2011
 



 

British Smaller Companies VCT2 plc ("the Company")

 

Interim Management Statement

For the quarter ended 31 March 2011

 

British Smaller Companies VCT2 plc presents its interim management statement for the quarter ended 31 March 2011. This constitutes the Company's first interim management statement for the financial year ending 31 December 2011, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.co.uk.

 

The total return at 31 March 2011, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, is 94.9 pence per share an increase of 0.5 pence per share in the quarter.

 

The unaudited net asset value per Ordinary share as at 31 March 2011 was 68.9p (31 December 2010: 68.4p). The 0.5p increase this quarter is the net result of a 1.3p per share increase in the value of the investments an operating loss of 0.3p and the 0.5p dilutive impact of the issue of shares.

 

The number of Ordinary shares in issue at 31 March 2011 was 20,934,196 (31 December 2010: 17,278,696). In addition at 31 March 2011 the Company held 566,100 shares in Treasury (31 December 2010: 566,100)

 

During the quarter the company raised £2.57 million by issuing 3,655,500 Ordinary Shares at a price of 70.25p per share pursuant to its linked offer for subscription with British Smaller Companies VCT plc ("Linked Offer").

 

Subsequent to the quarter end, pursuant to the Linked Offer, a further £1.35 million was raised by issuing a further 1,921,901 shares on 5 April 2011 and a final £0.47 million was raised through the issue of 690,699 shares on 4 May 2011 at a price of 70.25p per share. The Linked Offer for both the tax year 2010/2011 and 2011/2012 is now closed.

 

In addition, the Company purchased 191,280 Ordinary shares of 10 pence each at a price of 58.25 pence per share. These shares were placed in Treasury.

 

Net assets at 31 March 2011 comprised the following:

 

£000

% of net assets

Unquoted investments at fair value

5,851

40.6

Quoted investments at bid price

1,347

9.3

Gilt investments

3,957

27.4

Total investments

11,155

77.3

Cash and cash equivalents

3,047

21.1

Other net current assets (liabilities)

231

1.6

Net assets

14,433

100.0

 

The ten largest investments by valuation at 31 March 2011 were as follows:

 

£000

% of net assets

Digital Healthcare Limited

1,128

7.8

Primal Pictures Limited

1,082

7.5

Immunobiology Limited

1,002

6.9

Deep-Secure Ltd

546

3.8

Bluebell Telecom Group Limited

500

3.5

Waterfall Services Limited

455

3.2

Pressure Technologies plc

450

3.1

Harvey Jones Limited

350

2.4

Brady plc

304

2.1

Sirigen Limited

267

1.9

Top ten investments

6,084

42.2

Other investments

1,114

7.7

Gilt investments

3,957

27.4

Total investments

11,155

77.3

 

Quoted investments are carried at bid price at 31 March 2011 less a discount for liquidity where necessary. Unquoted investment are carried at fair value as 31 March 2011 as determined by the directors.

 

There were no investments or disposals during the three months ended 31 March 2011.

 

Performance

 

In this period the Company has seen its net asset value increase by 0.5p per share. The net asset value excluding the impact of the new issue of shares increased by 1.0p per share (1.5%), with increases seen in both the unquoted and quoted portfolios.

 

The total return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased by 0.5p to 94.9p per share, of which cumulative dividends represent 28.0p per share.

 

The net asset value currently comprises 48.8% in cash and gilts which in the short term will further increase following the share allotments and as such the Company is well placed to take advantage of selective investment opportunities as they arise enabling it to further diversify its portfolio of investments.

 

Dividend Re-investment scheme

 

The Company recently introduced a dividend re-investment scheme. Should the final dividend be approved at the AGM this will be the first dividend eligible under the scheme.

 

Share Buyback Policy

 

Prior to the Annual General Meeting held on 16 May 2011 the board of Directors withdrew the resolution proposed in the notice of the Annual General Meeting to renew the Company's authority to purchase its own shares. Although a majority of shareholders voting, including those voting by proxy, had indicated their support for the proposal, a significant minority were opposed. With this in mind the Directors withdrew the resolution prior to the meeting and intend to consult with shareholders in the coming months with a view to obtaining the necessary authority to re-introduce the share buyback policy. A further announcement will be made, as appropriate, in due course.

 

Investor Workshops

 

The Company remains committed to enhancing Shareholder communications and has presented annual investor workshops for a number of years which have proved very popular with Shareholders. The most recent event held on 9 February 2011 at the British Museum welcomed over 150 Shareholders.

 

Outlook

 

The Company has raised a total of £4.02m from the recent Linked Offer with British Smaller Companies VCT plc which will be used to support and diversify the investment portfolio over the coming years.

 

There is increasing evidence of businesses searching for capital and looking to expand which your Board believes will translate into increasing investment opportunities over both the short and medium term. The Company is well placed to take advantage of these investment opportunities as well as continuing to support its existing investments.

 

 

19 May 2011

 

For further information please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 294 5039

Jeff Keating Singer Capital Markets Limited Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMKRLNGMZG
Date   Source Headline
6th May 20267:00 amRNSDividend Declaration
20th Apr 202610:01 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:12 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNSAnnual Financial Report
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:31 amRNSDirector/PDMR Shareholding
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSInterim Management Statement
20th Nov 20259:00 amRNSOffer Update
31st Oct 202510:01 amRNSPayment of dividend and issue of Equity
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
22nd Aug 202510:45 amRNSNew combined offer for subscription
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 202510:20 amRNSPayment of Dividend and Issue of Equity
13th Jun 20251:30 pmRNSInterim Management Statement
12th Jun 202510:46 amRNSResult of AGM
13th May 202512:54 pmRNSDividend Declaration
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:15 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNSAnnual Financial Report
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:21 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
17th Dec 20242:13 pmRNSNominal Capital Reduction
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:08 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNS3rd Quarter Results
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
12th Nov 20241:52 pmRNSResult of General Meeting
1st Nov 202411:04 amRNSPayment of Dividend and Allotment of Shares
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.